Top Markets
#1 Songbird Songbird +11.52%
#2 pipedog pipedog +7.75%
#3 Collector Crypt Collector Crypt +6.31%
#4 Cryptopia Cryptopia +5.90%
#5 DAPPOS DAPPOS +4.59%
#6 OpenGradient OpenGradient +3.93%
#7 Moolah Moolah +3.64%
#8 Liquity Liquity +3.60%
#9 Pearl Pearl +3.36%
#10 Clearpool Clearpool +3.26%
Coin of the day
Songbird Songbird
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Beta Bionics, Inc. Beta Bionics, Inc.

Beta Bionics, Inc.

BBNX
Classifica tra le azioni #10096
Beta Bionics, Inc. is a commercial-stage medical technology company dedicated... Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to inventing, developing, and bringing to market solutions that improve the health and quality of life for individuals with diabetes who depend on insulin. The company's flagship product, the iLet Bionic Pancreas, is an automated insulin delivery system currently available for treating type 1 diabetes in adults and children aged six and older. In addition to its existing offering, Beta Bionics is actively developing several new innovations: a Patch Pump, designed as a tubeless insulin pump that adheres directly to the skin; the Bihormonal iLet, which integrates automated delivery of both insulin and glucagon; and an iLet system specifically adapted for individuals with insulin-dependent type 2 diabetes. To support its product pipeline, the company has forged strategic alliances, including a collaboration and licensing agreement with Xeris Pharmaceuticals, Inc. to develop and commercialize a glucagon formulation compatible with pumps. It also holds a development and commercialization agreement with Abbott Diabetes Care Inc. for an automated insulin delivery system. Established in 2015, Beta Bionics is headquartered in Irvine, California.
Prezzo delle azioni
$19.81
Ultima sincronizzazione: 2026-08-28
Capitalizzazione di mercato
$891.32M
Variazione (1 giorno)
1.39%
Variazione (1 anno)
5.16%
Paese
US
Scambia Beta Bionics, Inc. (BBNX)

Categoria

Healthcare
EPS per Beta Bionics, Inc. (BBNX)
EPS al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Beta Bionics, Inc., l’EPS attuale della società (TTM) è 0. Alla fine del 2026, la società aveva un EPS di 0 uguale a rispetto a quello del 2026, che era di 0.
Storico EPS per Beta Bionics, Inc. da 2026 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
Non abbastanza dati per le date fornite.
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $3.11 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $9.73 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $3.59 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $2.48 -
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE